Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | VALBENAZINE (INGREZZA) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | BRANDED CORTICOSTEROID AND NSAID | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | RAYOS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | METHYLERGONOVINE (METHERGINE) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | DUPIXENT | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | EPINEPHRINE | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | UM NETRESULTS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | DUCHENNE MUSCULAR DYSTROPY | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | OTEZLA | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | PROGESTERONE THERAPY AS A TECHNIQUE TO REDUCE PRETERM BIRTH IN HIGH-RISK PREGNANCIES | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | METHYLERGONOVINE (METHERGINE) FOR MIGRAINE PROPHYLAXIS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ADYNOVATE | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | DURLAZA | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | GLUMETZA | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ANDROGENS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ASTHMA MANAGEMENT | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | PCSK9 | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | CHOLBAM | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATORS (CFTR) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | BLINCYTO/ BLINATUMOMAB | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | LENVIMA/LENVATNIB | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | NORTHERA/DROXIDOPA | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | NATPARA | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | CDK4/6 INHIBITORS FOR BREAST CANCER | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | PROGRAMMED CELL DEATH (PD-1) INHIBITOR | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | OLAPARIB (LYNPARZA) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MYALEPT (METRELEPTIN) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | INSULIN | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | TREATMENT FOR IDIOPATHIC PULMONARY FIBROSIS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | HETLIOZ (TASIMELTEON) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | PHARMACOLOGIC TREATMENT OF SLEEP DISORDERS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | CETUXIMAB/ ERBITUX | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | QUANTITY LIMIT PROGRAM | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | BIOLOGICS FOR GASTROINTESTINAL DISEASE | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | BIOLOGICS FOR PLAQUE PSORIASIS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | BIOLOGICS FOR RHEUMATIC DISORDERS AND HIDRADENITIS SUPPURATIVE | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | INTRAVENOUS/SUBCUTANEOUS IMMUNE GLOBULIN | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | TEDUGLUTIDE (GATTEX) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | DIABETIC GLUCOSE TEST STRIPS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | COMPOUNDED TOPICAL PAIN CREAMS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ZIV-AFLIBERCEPT/ZALTRAP | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | IVACAFTOR (KALYDECO) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | OXYCONTIN QUANTITY LIMITS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | KRYSTEXXA/ PEGLOTICASE | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SYSTEMIC LUPUS ERYTHRATHEMATOSUS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | TREATMENT FOR HEPATITIS C | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | DISEASE MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | CELLULAR IMMUNOTHERAPY FOR PROSTATE CANCER | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | QUTENZA/ CAPSAICIN 8% PATCH | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | KINASE INHIBITORS | New policy |